Cargando…

Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem

Most monoclonal antibodies (mAbs) generated from humans infected or vaccinated with the 2009 pandemic H1N1 (pdmH1N1) influenza virus targeted the hemagglutinin (HA) stem. These anti-HA stem mAbs mostly used IGHV1-69 and bound readily to epitopes on the conventional seasonal influenza and pdmH1N1 vac...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomson, C. A., Wang, Y., Jackson, L. M., Olson, M., Wang, W., Liavonchanka, A., Keleta, L., Silva, V., Diederich, S., Jones, R. B., Gubbay, J., Pasick, J., Petric, M., Jean, François, Allen, V. G., Brown, E. G., Rini, J. M., Schrader, J. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3347682/
https://www.ncbi.nlm.nih.gov/pubmed/22586427
http://dx.doi.org/10.3389/fimmu.2012.00087
_version_ 1782232312916738048
author Thomson, C. A.
Wang, Y.
Jackson, L. M.
Olson, M.
Wang, W.
Liavonchanka, A.
Keleta, L.
Silva, V.
Diederich, S.
Jones, R. B.
Gubbay, J.
Pasick, J.
Petric, M.
Jean, François
Allen, V. G.
Brown, E. G.
Rini, J. M.
Schrader, J. W.
author_facet Thomson, C. A.
Wang, Y.
Jackson, L. M.
Olson, M.
Wang, W.
Liavonchanka, A.
Keleta, L.
Silva, V.
Diederich, S.
Jones, R. B.
Gubbay, J.
Pasick, J.
Petric, M.
Jean, François
Allen, V. G.
Brown, E. G.
Rini, J. M.
Schrader, J. W.
author_sort Thomson, C. A.
collection PubMed
description Most monoclonal antibodies (mAbs) generated from humans infected or vaccinated with the 2009 pandemic H1N1 (pdmH1N1) influenza virus targeted the hemagglutinin (HA) stem. These anti-HA stem mAbs mostly used IGHV1-69 and bound readily to epitopes on the conventional seasonal influenza and pdmH1N1 vaccines. The anti-HA stem mAbs neutralized pdmH1N1, seasonal influenza H1N1 and avian H5N1 influenza viruses by inhibiting HA-mediated fusion of membranes and protected against and treated heterologous lethal infections in mice with H5N1 influenza virus. This demonstrated that therapeutic mAbs could be generated a few months after the new virus emerged. Human immunization with the pdmH1N1 vaccine induced circulating antibodies that when passively transferred, protected mice from lethal, heterologous H5N1 influenza infections. We observed that the dominant heterosubtypic antibody response against the HA stem correlated with the relative absence of memory B cells against the HA head of pdmH1N1, thus enabling the rare heterosubtypic memory B cells induced by seasonal influenza and specific for conserved sites on the HA stem to compete for T-cell help. These results support the notion that broadly protective antibodies against influenza would be induced by successive vaccination with conventional influenza vaccines based on subtypes of HA in viruses not circulating in humans.
format Online
Article
Text
id pubmed-3347682
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Frontiers Research Foundation
record_format MEDLINE/PubMed
spelling pubmed-33476822012-05-14 Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem Thomson, C. A. Wang, Y. Jackson, L. M. Olson, M. Wang, W. Liavonchanka, A. Keleta, L. Silva, V. Diederich, S. Jones, R. B. Gubbay, J. Pasick, J. Petric, M. Jean, François Allen, V. G. Brown, E. G. Rini, J. M. Schrader, J. W. Front Immunol Immunology Most monoclonal antibodies (mAbs) generated from humans infected or vaccinated with the 2009 pandemic H1N1 (pdmH1N1) influenza virus targeted the hemagglutinin (HA) stem. These anti-HA stem mAbs mostly used IGHV1-69 and bound readily to epitopes on the conventional seasonal influenza and pdmH1N1 vaccines. The anti-HA stem mAbs neutralized pdmH1N1, seasonal influenza H1N1 and avian H5N1 influenza viruses by inhibiting HA-mediated fusion of membranes and protected against and treated heterologous lethal infections in mice with H5N1 influenza virus. This demonstrated that therapeutic mAbs could be generated a few months after the new virus emerged. Human immunization with the pdmH1N1 vaccine induced circulating antibodies that when passively transferred, protected mice from lethal, heterologous H5N1 influenza infections. We observed that the dominant heterosubtypic antibody response against the HA stem correlated with the relative absence of memory B cells against the HA head of pdmH1N1, thus enabling the rare heterosubtypic memory B cells induced by seasonal influenza and specific for conserved sites on the HA stem to compete for T-cell help. These results support the notion that broadly protective antibodies against influenza would be induced by successive vaccination with conventional influenza vaccines based on subtypes of HA in viruses not circulating in humans. Frontiers Research Foundation 2012-05-08 /pmc/articles/PMC3347682/ /pubmed/22586427 http://dx.doi.org/10.3389/fimmu.2012.00087 Text en Copyright © 2012 Thomson, Wang, Jackson, Olson, Wang, Liavonchanka, Keleta, Silva, Diederich, Jones, Gubbay, Pasick, Petric, Jean, Allen, Brown, Rini and Schrader. http://www.frontiersin.org/licenseagreement This is an open-access article distributed under the terms of the Creative Commons Attribution Non Commercial License, which permits non-commercial use, distribution, and reproduction in other forums, provided the original authors and source are credited.
spellingShingle Immunology
Thomson, C. A.
Wang, Y.
Jackson, L. M.
Olson, M.
Wang, W.
Liavonchanka, A.
Keleta, L.
Silva, V.
Diederich, S.
Jones, R. B.
Gubbay, J.
Pasick, J.
Petric, M.
Jean, François
Allen, V. G.
Brown, E. G.
Rini, J. M.
Schrader, J. W.
Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem
title Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem
title_full Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem
title_fullStr Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem
title_full_unstemmed Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem
title_short Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem
title_sort pandemic h1n1 influenza infection and vaccination in humans induces cross-protective antibodies that target the hemagglutinin stem
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3347682/
https://www.ncbi.nlm.nih.gov/pubmed/22586427
http://dx.doi.org/10.3389/fimmu.2012.00087
work_keys_str_mv AT thomsonca pandemich1n1influenzainfectionandvaccinationinhumansinducescrossprotectiveantibodiesthattargetthehemagglutininstem
AT wangy pandemich1n1influenzainfectionandvaccinationinhumansinducescrossprotectiveantibodiesthattargetthehemagglutininstem
AT jacksonlm pandemich1n1influenzainfectionandvaccinationinhumansinducescrossprotectiveantibodiesthattargetthehemagglutininstem
AT olsonm pandemich1n1influenzainfectionandvaccinationinhumansinducescrossprotectiveantibodiesthattargetthehemagglutininstem
AT wangw pandemich1n1influenzainfectionandvaccinationinhumansinducescrossprotectiveantibodiesthattargetthehemagglutininstem
AT liavonchankaa pandemich1n1influenzainfectionandvaccinationinhumansinducescrossprotectiveantibodiesthattargetthehemagglutininstem
AT keletal pandemich1n1influenzainfectionandvaccinationinhumansinducescrossprotectiveantibodiesthattargetthehemagglutininstem
AT silvav pandemich1n1influenzainfectionandvaccinationinhumansinducescrossprotectiveantibodiesthattargetthehemagglutininstem
AT diederichs pandemich1n1influenzainfectionandvaccinationinhumansinducescrossprotectiveantibodiesthattargetthehemagglutininstem
AT jonesrb pandemich1n1influenzainfectionandvaccinationinhumansinducescrossprotectiveantibodiesthattargetthehemagglutininstem
AT gubbayj pandemich1n1influenzainfectionandvaccinationinhumansinducescrossprotectiveantibodiesthattargetthehemagglutininstem
AT pasickj pandemich1n1influenzainfectionandvaccinationinhumansinducescrossprotectiveantibodiesthattargetthehemagglutininstem
AT petricm pandemich1n1influenzainfectionandvaccinationinhumansinducescrossprotectiveantibodiesthattargetthehemagglutininstem
AT jeanfrancois pandemich1n1influenzainfectionandvaccinationinhumansinducescrossprotectiveantibodiesthattargetthehemagglutininstem
AT allenvg pandemich1n1influenzainfectionandvaccinationinhumansinducescrossprotectiveantibodiesthattargetthehemagglutininstem
AT browneg pandemich1n1influenzainfectionandvaccinationinhumansinducescrossprotectiveantibodiesthattargetthehemagglutininstem
AT rinijm pandemich1n1influenzainfectionandvaccinationinhumansinducescrossprotectiveantibodiesthattargetthehemagglutininstem
AT schraderjw pandemich1n1influenzainfectionandvaccinationinhumansinducescrossprotectiveantibodiesthattargetthehemagglutininstem